Paper32671191
Mode of nitric oxide delivery affects antibacterial action.
Hall JR and 5 others. ACS Biomater Sci Eng, 2020. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Mode of nitric oxide delivery affects antibacterial action. Papers, record 32671191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32671191
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Nitric Oxide | Major topic |
| Animals | |
| Gram-Negative Bacteria | |
| Gram-Positive Bacteria | |
| Reproducibility of Results |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DE025207 | NIDCR NIH HHS | United States | R01DE025207 | PubMed and NIH |
Source NIH RePORTER
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20852503 | Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. | J Wound Care | 2010 | https://conductscience.org/library/papers/20852503 | PubMed |
| 2 | 15378046 | Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. | Nat Rev Microbiol | 2004 | https://conductscience.org/library/papers/15378046 | PubMed |
| 3 | 21279860 | Chemical and antimicrobial treatments change the viscoelastic properties of bacterial biofilms. | Biofouling | 2011 | https://conductscience.org/library/papers/21279860 | PubMed |
| 4 | 22349019 | Examination of bacterial resistance to exogenous nitric oxide. | Nitric Oxide | 2012 | https://conductscience.org/library/papers/22349019 | PubMed |
| 5 | 9185502 | Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9185502 | PubMed |
| 6 | 20836577 | Aztreonam lysine for inhalation solution: in cystic fibrosis. | Drugs | 2010 | https://conductscience.org/library/papers/20836577 | PubMed |
| 7 | 17337677 | Hypertonic saline inhalation in cystic fibrosis--salt in the wound, or sweet success? | Arch Dis Child | 2007 | https://conductscience.org/library/papers/17337677 | PubMed |
| 8 | 15691583 | Nitric oxide, cell signaling and cell death. | Toxicology | 2005 | https://conductscience.org/library/papers/15691583 | PubMed |
| 9 | 17185047 | Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study. | J Cyst Fibros | 2007 | https://conductscience.org/library/papers/17185047 | PubMed |
| 10 | 11568993 | Efficacy and safety of aerosolized tobramycin in cystic fibrosis. | Pediatr Pulmonol | 2001 | https://conductscience.org/library/papers/11568993 | PubMed |
| 11 | 25278817 | Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy. | Core Evid | 2014 | https://conductscience.org/library/papers/25278817 | PubMed |
| 12 | 18789393 | Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. | Nitric Oxide | 2009 | https://conductscience.org/library/papers/18789393 | PubMed |
| 13 | 21719889 | Mechanisms and applications of hypertonic saline. | J R Soc Med | 2011 | https://conductscience.org/library/papers/21719889 | PubMed |
| 14 | 26861246 | Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study. | Infection | 2016 | https://conductscience.org/library/papers/26861246 | PubMed |
| 15 | 26287799 | Encapsulation of N-Diazeniumdiolates within Liposomes for Enhanced Nitric Oxide Donor Stability and Delivery. | Mol Pharm | 2015 | https://conductscience.org/library/papers/26287799 | PubMed |
| 16 | 26717238 | Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release. | ACS Appl Mater Interfaces | 2016 | https://conductscience.org/library/papers/26717238 | PubMed |
| 17 | 29756275 | Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications. | Adv Healthc Mater | 2018 | https://conductscience.org/library/papers/29756275 | PubMed |
| 18 | 24268196 | Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents. | Biomaterials | 2014 | https://conductscience.org/library/papers/24268196 | PubMed |
| 20 | 26855790 | Nitric oxide generating/releasing materials. | Future Sci OA | 2015 | https://conductscience.org/library/papers/26855790 | PubMed |
| 21 | 23481089 | Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia. | J Cyst Fibros | 2013 | https://conductscience.org/library/papers/23481089 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42107246 | Nitric oxide-releasing responsive biomaterials for antimicrobial skin therapy. | Redox Biol | 2026 | https://conductscience.org/library/papers/42107246 | PubMed |
| 42064878 | Treatment of periodontal biofilms via nitric oxide-augmented phototherapy. | J Oral Microbiol | 2026 | https://conductscience.org/library/papers/42064878 | PubMed |
| 41594093 | Nitric Oxide-Releasing Gels in the Context of Antimicrobial Stewardship, Biofilm Management, and Wound-Repair Biology. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/41594093 | PubMed |
| 41302490 | Photoresponsive Ru Complex-Gold Nanoparticle Hybrids for Theranostics: A Theoretical Study of Electronic Structure and Luminescence-Based Detection. | Molecules | 2025 | https://conductscience.org/library/papers/41302490 | PubMed |
| 40438154 | Nitrite Reductases in Biomedicine: From Natural Enzymes to Artificial Mimics. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/40438154 | PubMed |
| 40133071 | Nitric Oxide Inhibition of Glycyl Radical Enzymes and Their Activases. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/40133071 | PubMed |
| 39770746 | Harnessing the Power of Our Immune System: The Antimicrobial and Antibiofilm Properties of Nitric Oxide. | Microorganisms | 2024 | https://conductscience.org/library/papers/39770746 | PubMed |
| 39596741 | Nanoparticle-Based Nitric Oxide Donors: Exploring Their Antimicrobial and Anti-Biofilm Capabilities. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39596741 | PubMed |
| 39564025 | Exploring Therapeutic Strategies for Pediatric Cystic Fibrosis: An In-Depth Comparative Review. | Cureus | 2024 | https://conductscience.org/library/papers/39564025 | PubMed |
| 39263842 | Enhanced Nitric Oxide Delivery Through Self-Assembling Nanoparticles for Eradicating Gram-Negative Bacteria. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/39263842 | PubMed |
| 38978720 | Antimicrobial properties of hindered amine light stabilizers in polymer coating materials and their mechanism of action. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/38978720 | PubMed |
| 38790647 | Blends of Organic Acids Are Weaponizing the Host iNOS and Nitric Oxide to Reduce Infection of Piscirickettsia salmonis in vitro. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38790647 | PubMed |
| 38620577 | Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms. | Appl Mater Today | 2021 | https://conductscience.org/library/papers/38620577 | PubMed |
| 38434900 | Copper-Cystine Biohybrid-Embedded Nanofiber Aerogels Show Antibacterial and Angiogenic Properties. | ACS Omega | 2024 | https://conductscience.org/library/papers/38434900 | PubMed |
| 38206003 | Nitric oxide-releasing prodrug for the treatment of complex Mycobacterium abscessus infections. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/38206003 | PubMed |
| 37980361 | Biofilm heterogeneity-adaptive photoredox catalysis enables red light-triggered nitric oxide release for combating drug-resistant infections. | Nat Commun | 2023 | https://conductscience.org/library/papers/37980361 | PubMed |
| 37733661 | Controlled and customizable baculovirus NOS3 gene delivery using PVA-based hydrogel systems. | PLoS One | 2023 | https://conductscience.org/library/papers/37733661 | PubMed |
| 37138646 | Staphylococcus aureus strains exhibit heterogenous tolerance to direct cold atmospheric plasma therapy. | Biofilm | 2023 | https://conductscience.org/library/papers/37138646 | PubMed |
| 36706864 | Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro. | Nitric Oxide | 2023 | https://conductscience.org/library/papers/36706864 | PubMed |
| 36406249 | Antibacterial gas therapy: Strategies, advances, and prospects. | Bioact Mater | 2023 | https://conductscience.org/library/papers/36406249 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32671191
GET https://conductscience.org/api/papers/v1/32671191/references?page=2